Phathom Pharmaceuticals Inc Financial Flexibility Index
Phathom Pharmaceuticals Inc financial flexibility index. Phathom Pharmaceuticals Inc (PHAT) has a Financial Flexibility Index of -0.02x as of September 2025. Free cash flow of $-14.09 Million (operating CF $-14.12 Million minus capex $27.00K) represents 0% of total liabilities ($662.82 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Phathom Pharmaceuticals Inc (2018–2024)
Financial flexibility index of Phathom Pharmaceuticals Inc from 2018 to 2024. Historical Financial Flexibility Index trend for Phathom Pharmaceuticals Inc across 7 annual periods. Explore Phathom Pharmaceuticals Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Phathom Pharmaceuticals Inc Financial Flexibility Index by Year (2018–2024)
Phathom Pharmaceuticals Inc financial flexibility index by year from 2018 to 2024. Year-by-year free cash flow to debt coverage for Phathom Pharmaceuticals Inc. For the full cash flow conversion analysis, see how efficiently does Phathom Pharmaceuticals Inc generate cash.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.42x | $-266.63 Million | $-266.77 Million | $631.90 Million | ▼ -51.0% |
| 2023 | -0.28x | $-135.95 Million | $-137.58 Million | $486.60 Million | ▲ +54.0% |
| 2022 | -0.61x | $-145.49 Million | $-146.53 Million | $239.62 Million | ▲ +51.9% |
| 2021 | -1.26x | $-148.13 Million | $-148.46 Million | $117.28 Million | ▼ -85.5% |
| 2020 | -0.68x | $-68.65 Million | $-69.69 Million | $100.84 Million | ▼ -76.7% |
| 2019 | -0.39x | $-11.26 Million | $-36.51 Million | $29.22 Million | ▲ +5.4% |
| 2018 | -0.41x | $-891.00K | $-1.02 Million | $2.19 Million | — |